Upper facial laxity micro-focused ultrasound laxity brow lifting
Conditions
Interventions
The subjects will be treated with Ultraformer MPT by applying ultrasound gel to the treatment area and using a circular cartridge in Micro pulsed mode, using a head capable of delivering 1.5 mm depth
Experimental Device
Sponsors
Faculty of Medicine Siriraj Hospital, Mahidol University
Quantum Healthcare(Thailand) Co.,Ltd.
Eligibility
Sex/Gender
All
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. A person who has mild to moderate sagging of the face that wants to lift the eyebrows. 2. Being a Thai person of Asian descent 3. Volunteers who voluntarily agree to participate in the project
Exclusion criteria
Exclusion criteria: 1. Pregnant women and breastfeeding women. 2. Had dermatitis, wounds, or skin infections on the face. 3. Subjects who had undergone thread lifting or face lifting devices or had facial surgery within 12 months of participating in the study. 4. Subjects with a history of receiving filler or botulinum toxin injections within 6 months before study participation. 5. Volunteers with uncontrolled heart disease, uncontrolled thyroid disease, autoimmune disease, taking immunosuppressant drugs, using a pacemaker, and having metal implants on the face. 6. Subjects have a history of hypertrophic scars or keloids. 7. Subjects with mental disorders whom a psychiatrist has diagnosed. 8. Subjects who are not allowed to take pictures for treatment evaluation 9. Subjects with excessive subcutaneous fat (ptotic fat) 10. Subjects taking NSAIDs, ASA, and steroids in the 72 hours before treatment 11. Subjects with a history of allergies to both injectable and topical anesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of wrinkles Before treatment, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after treatment Antera 3D analysis,Eyebrow height Before treatment, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after treatment Measuring from pictures using ImageJ software | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events 2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after treatment Clinical evaluation | — |
Countries
Thailand
Contacts
Public ContactThrit Hutachoke
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed